News/ News/ Oncology FDA sets May date for verdict on ADC’s lymphoma drug Lonca Phil Taylor ADC Therapeutics, antibody-drug conjugate, CART, diffuse B-Cell lymphoma, loncastuximab tesirine, non-Hodgkin lymphoma 0 Comment ADC Therapeutics could claim its first product approval in the US next May, after the FDA started a Share X FDA sets May date for verdict on ADC’s lymphoma drug Lonca https://pharmaphorum.com/news/fda-sets-may-date-for-verdict-on-adcs-lymphoma-drug-lonca/